https://www.selleckchem.com/products/AZD5438.html
Ferric citrate hydrate (FC), an oral iron product is approved as iron preparation for iron deficiency anemia and phosphate binder for chronic kidney disease (CKD). We investigated whether gastric acid secretion inhibitors (GASI) influenced on iron absorption and phosphate-lowering effects of FC. Two phase 3 studies of FC for treatment of hyperphosphatemia in CKD patients (non-dialysis-dependent, 12weeks, and hemodialysis, 52weeks), were retrospectively analyzed. Patients were divided into with or without concomitant GASI and levels of i
Like
Comment
Share
